Publikasjoner
- Benchmarking emerging chromatographic platforms for mRNA-LNP characterization and scalable process enablement
- Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines
- Interactions between mRNA lipid nanoparticles and immune cells in fresh human whole blood Les publikasjonen
- Multiparameter characterisation of a nano-polypropylene representative test material with fractionation, light scattering, high-resolution microscopy, spectroscopy, and spectrometry methods Les publikasjonen
- Toward an international standardisation roadmap for nanomedicine
- Urea supplementation improves mRNA in vitro transcription by decreasing both shorter and longer RNA byproducts Les publikasjonen
- Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon (Salmo salar) Les publikasjonen
- Quality assessment of LNP-RNA therapeutics with orthogonal analytical techniques Les publikasjonen
- Cryo-XPS for Surface Characterization of Nanomedicines Les publikasjonen
- Physicochemical characterization and quantification of nanoplastics: applicability, limitations and complementarity of batch and fractionation methods Les publikasjonen
Annen formidling
- Her tester forskerne en ny type medisiner ved hjelp av menneskeblod
- MONOLITH LIQUID CHROMATOGRAPHY FOR RECOVERY AND PURIFICATION OF INTACT LIPID NANOPARTICLES SHOWS FULL IN VIVO COMPATIBILITY
- Development of mRNA lipid nanoparticles for the delivery of gene editing tools to the lungs
- WS05.01Lipid nanoparticles and vesicles delivery tools to deliver mRNA and ribonucleoprotein to the lungs for the development of genome editing in cystic fibrosis
- RNA-LNP – Quality control
- Why advanced, orthogonal analytics is crucial in LNP development – and how we might get rid of TFF
- Characterization of nucleic acids using Asymmetrical Flow Field-Flow Fractionation (AF4)
- HPLC separation of intact LNPs
- Production and analysis methods for pristine and degraded microplastic and nanoplastic reference materials
- Supporting the Development of Next-generation Nucleotide-based Therapeutics, including ASOs and mRNA, with High-resolution Analytical Techniques